Orange Book product · Brand (NDA)
LOPRESSOR
METOPROLOL TARTRATE
At a glance
Apr 10, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 10, 2025
1 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
METOPROLOL TARTRATE
Strength
10MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 219373
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025LOPRESSORBrand (NDA)
NDA 218698 · XTM CONSULTING
- 1984LOPRESSORBrand (NDA)
NDA 018704 · NOVARTIS
- —LOPRESSORBrand (NDA)
NDA 017963 · VALIDUS PHARMS
- 2023METOPROLOL TARTRATEGeneric (ANDA)
ANDA 212402 · ZYDUS PHARMS
- 2020METOPROLOL TARTRATEGeneric (ANDA)
ANDA 208955 · SCIEGEN PHARMS
- 2014METOPROLOL TARTRATEGeneric (ANDA)
ANDA 200981 · RUBICON RESEARCH
- 2014METOPROLOL TARTRATEGeneric (ANDA)
ANDA 204205 · GLAND
- 2013METOPROLOL TARTRATEGeneric (ANDA)
ANDA 202871 · ALEMBIC PHARMS LTD
- 2013METOPROLOL TARTRATEGeneric (ANDA)
ANDA 078950 · BAXTER HLTHCARE CORP
- 2010METOPROLOL TARTRATEGeneric (ANDA)
ANDA 091307 · LUITPOLD
- 2010METOPROLOL TARTRATEGeneric (ANDA)
ANDA 091045 · FRESENIUS KABI USA
- 2010METOPROLOL TARTRATEGeneric (ANDA)
ANDA 090317 · ONESOURCE SPECIALTY
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
